当前位置: 首页 > 期刊 > 《中国当代医药》 > 2016年第26期 > 正文
编号:12949059
慢性结石性胆囊炎与胆囊癌关系的研究进展(4)
http://www.100md.com 2016年9月15日 《中国当代医药》2016年第26期
     [19]Ghosh N,Chaki R,Mandal V,et al.COX-2 as a target for cancer chemotherapy[J].Pharmacol Rep,2010,62(2):233-244.

    [20]Liu E,Sakoda LC,Gao YT,et al.Aspirin use and risk of biliary tract cancer:a population-based study in Shanghai,China[J].Cancer Epidemiol Biomarkers Prev,2005,14(5):1315-1318.

    [21]Aleksandrova K,Boeing H,N?觟thlings U,et al.Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer[J].Hepatology,2014,60(3):858-871.

    [22]Kemp TJ,Castro FA,Gao YT,et al.Application of multiplex arrays for cytokine and chemokine profiling of bile[J].Cytokine,2015,73(1):84-90.

    [23]Ehling J,Tacke F.Role of chemokine pathways in hepatobiliary cancer[J].Cancer Lett,2015,379(2):173-183.

    [24]Steffensen KR,Jakobsson T,Gustafsson J.Targeting liver X receptors in inflammation[J].Expert Opin Ther Targets,2013,17(8):977-990.

    [25]Gabbi C,Kim HJ,Barros R,et al.Estrogen-dependent gallbladder carcinogenesis in LXRbeta-/- female mice[J].Proc Natl Acad Sci USA,2010,107(33):14763-14768.

    [26]中华医学会外科学分会胆道外科学组.胆囊癌诊断和治疗指南(2015版)[J].中华消化外科杂志,2015,14(11):881-890.

    [27]董臣.意外胆囊癌治疗的研究进展[J].中国普通外科杂志,2014,23(2):236-239.

    (收稿日期:2016-08-02 本文编辑:方菊花) (邹荣基 马庆久)
上一页1 2 3 4